| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/27/2003 | EP1337670A1 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies |
| 08/27/2003 | EP1337669A2 Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion |
| 08/27/2003 | EP1337668A2 Method for detecting methylation states for a toxicological diagnostic |
| 08/27/2003 | EP1337665A2 Immobilization of biopolymers to aminated substrates by direct adsorption |
| 08/27/2003 | EP1337664A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 08/27/2003 | EP1337663A2 Determination of the ability of patients to respond to tumour treatment |
| 08/27/2003 | EP1337661A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 08/27/2003 | EP1337657A2 Heterologous expression of taxanes |
| 08/27/2003 | EP1337656A1 In vitro generation of recombinant adenovirus vectors |
| 08/27/2003 | EP1337655A2 Retroviral vectors containing internal ribosomal entry sites |
| 08/27/2003 | EP1337654A2 Tissue specific promoters |
| 08/27/2003 | EP1337653A2 Controlled environment agriculture bioreactor for heterologous protein production |
| 08/27/2003 | EP1337652A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
| 08/27/2003 | EP1337651A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 08/27/2003 | EP1337650A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 08/27/2003 | EP1337649A1 Nucleotide sequences which code for the mtra and mtrb gene |
| 08/27/2003 | EP1337648A2 Novel cyclodextrin glucanotransferase (cgtase), obtained from i bacillus agaradherens /i (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
| 08/27/2003 | EP1337646A2 Genes of the 1-desoxy-d-xylulose biosynthesis path |
| 08/27/2003 | EP1337645A2 Rhodococcus cloning and expression vectors |
| 08/27/2003 | EP1337644A2 Aspergillus fumigatus profilin |
| 08/27/2003 | EP1337643A1 Manipulation of plant life cycles and/or growth phases |
| 08/27/2003 | EP1337642A1 Cytokin-like proteins |
| 08/27/2003 | EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 08/27/2003 | EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379 |
| 08/27/2003 | EP1337639A2 Master bone formation transcription factor: compositions and methods of use |
| 08/27/2003 | EP1337638A2 Adipocyte complement related protein zacrp13 |
| 08/27/2003 | EP1337637A2 Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides |
| 08/27/2003 | EP1337636A2 Soluble zcytor 11 cytokine receptors |
| 08/27/2003 | EP1337635A2 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/27/2003 | EP1337634A2 Novel polypeptides involved in immune response |
| 08/27/2003 | EP1337633A2 Anti-angiogenic proteins and fragments and methods of use thereof |
| 08/27/2003 | EP1337632A2 Differentiated cells suitable for human therapy |
| 08/27/2003 | EP1337631A2 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 08/27/2003 | EP1337630A2 Modified arginine deiminase |
| 08/27/2003 | EP1337626A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 08/27/2003 | EP1337560A2 Truncated cd200 |
| 08/27/2003 | EP1337559A2 Regulation of human nmda receptor |
| 08/27/2003 | EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 08/27/2003 | EP1337556A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 08/27/2003 | EP1337554A2 Novel compounds |
| 08/27/2003 | EP1337552A2 Light-driven energy generation using proteorhodopsin |
| 08/27/2003 | EP1337545A2 Antisense modulation of src-1 expression |
| 08/27/2003 | EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 08/27/2003 | EP1337543A1 Streptavidin-binding peptides and uses thereof |
| 08/27/2003 | EP1337542A2 Method for removing a universal linker from an oligonucleotide |
| 08/27/2003 | EP1337541A2 Massive parallel method for decoding DNA and RNA |
| 08/27/2003 | EP1337325A2 Acoustic ejection of fluids from a plurality of reservoirs |
| 08/27/2003 | EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 08/27/2003 | EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 08/27/2003 | EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 08/27/2003 | EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/27/2003 | EP1337149A2 Vaccine immunotherapy for immune suppressed patients |
| 08/27/2003 | EP1337140A2 Methods and compositions for the introduction of molecules into cells |
| 08/27/2003 | EP1267834A4 Cationic liposomes |
| 08/27/2003 | EP1259597A4 Zinc finger domains and methods of identifying same |
| 08/27/2003 | EP1208211A4 Means and methods for modifying gene expression using unpolyadenylated rna |
| 08/27/2003 | EP1187921A4 Compositions affecting programmed cell death and their use in the modification of forestry plant development |
| 08/27/2003 | EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids |
| 08/27/2003 | EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS |
| 08/27/2003 | EP1112077A4 Method for detection of biological factors in epidermis |
| 08/27/2003 | EP1110086A4 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 08/27/2003 | EP1061951B1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 08/27/2003 | EP1053347A4 Peptide detection method |
| 08/27/2003 | EP1046036A4 Methods for obtaining probes of peptide function |
| 08/27/2003 | EP1042368B1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 08/27/2003 | EP0938589B1 Method of identifying pharmaceuticals from plant extracts |
| 08/27/2003 | EP0932625B1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 08/27/2003 | EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 08/27/2003 | EP0895546B1 Methods of isolating biological target materials using silica magnetic particles |
| 08/27/2003 | EP0871712B1 Transglutaminases from oomycetes |
| 08/27/2003 | EP0870199A4 Assays for growth hormone secretagogue receptors |
| 08/27/2003 | EP0832186B1 Replacement therapy for dental caries |
| 08/27/2003 | EP0830600B1 Functional bioassay for g-protein coupled receptor agonists and antagonists |
| 08/27/2003 | EP0821693B1 Novel human cytomegalovirus dna sequences |
| 08/27/2003 | EP0795008B1 Human hypertrophic chondrocyte cell-lines |
| 08/27/2003 | EP0760002B1 Detection of mutation by resolvase cleavage |
| 08/27/2003 | EP0750458B1 Terminal complement inhibitor fusion genes and proteins |
| 08/27/2003 | EP0706566B1 Conotoxins having acetylcholine receptor binding properties |
| 08/27/2003 | EP0667910B1 A bacillus promoter derived from a variant of a bacillus licheniformis alpha-amylase promoter |
| 08/27/2003 | CN1439059A Method of identifying a plant extract |
| 08/27/2003 | CN1439056A Herpes viruses for immune modulation |
| 08/27/2003 | CN1439055A Novel recombinant adenovirus vector with relieved side effects |
| 08/27/2003 | CN1439054A Changing fine chemical content in organisms by genetically modifying shikimate pathway |
| 08/27/2003 | CN1439053A Non-endogenous, constitutively activated hyman G protein-coupled receptors |
| 08/27/2003 | CN1439049A Hepatocyte lineage cells derived from pluripotent stem cells |
| 08/27/2003 | CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/27/2003 | CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators |
| 08/27/2003 | CN1439020A Biosynthetic oncolytic molecules and uses therefor |
| 08/27/2003 | CN1439017A Novel compounds |
| 08/27/2003 | CN1438988A Use of compositions consisting of cations compounds and proton donors for stabilizing and/or separating nucleic acids or from micro-organism such as prokaryots, protozoa or algae |
| 08/27/2003 | CN1438896A Vaccine comprising a tick cement protein |
| 08/27/2003 | CN1438479A Technology for sorting and extracting matter in liquid cell using laser |
| 08/27/2003 | CN1438323A Genetic-sorting model of zinc finger-protein-DNA interaction and use thereof |
| 08/27/2003 | CN1438317A Method for producing purposive protein using homologous recombination method to obtain transgenosis tussah |
| 08/27/2003 | CN1438316A Method for expressing human's egg transparent band 2P3 protein in saccharomycetes expression system |
| 08/27/2003 | CN1438315A Beta-lactamase/amino-glucosidic passive zyme interfused gene, its expressed products and composition thereof and use |
| 08/27/2003 | CN1438242A Systhesizing of chimeric peptide from anteron promoted by human's fine hair |
| 08/27/2003 | CN1438241A Reverse-corelation-resisting signal transfer gene of plant and protein coded thereof |
| 08/27/2003 | CN1438239A Novel fluorescent proteinÒÇüpolynucleotide series coded thereof and use |
| 08/27/2003 | CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof |